CD34+CD38− lymphoblasts as likely leukemia stem cells (LSCs) may be responsible for a worse response to treatment and may be a risk factor for recurrence in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). The gene discussed is CD38; the disease is precursor B-cell acute lymphoblastic leukemia.